Published 2016
| Version v1
Publication
Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn's disease.
Additional details
- URL
- http://hdl.handle.net/11567/830083
- URN
- urn:oai:iris.unige.it:11567/830083
- Origin repository
- UNIGE